Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Percutaneous umbilical cord blood sampling Stories

2012-11-09 08:28:06

REDWOOD CITY, Calif., Nov. 9, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced two poster presentations at the 62(nd) Annual Meeting of the American Society of Human Genetics (ASHG). The conference is being held in San Francisco, California. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) "The verifi® prenatal test offers pregnant women access to a blood test that is safe, early and accurate,"...

2011-08-08 06:47:16

According to new study in the Journal of Molecular Diagnostics Researchers have demonstrated the feasibility of focused fetal gene expression analysis of target genes found in amniotic fluid using Standardized NanoArray PCR (SNAP) technology. This analysis could be used to monitor fetal development, enabling clinicians to determine very early in pregnancy whether fetal organ systems are developing normally. The study appears today in the September issue of The Journal of Molecular...

2009-07-07 13:15:00

A study of more than 64,000 pregnant women has found that miscarriage rates following amniocentesis and chorionic villus sampling (CVS) - two invasive procedures to detect chromosomal abnormalities and birth defects - were 1.4 per cent and 1.9 per cent, respectively.The research, published in the July issue of Ultrasound in Obstetrics and Gynecology, also found that the number of procedures carried out by a department had a significant effect on miscarriage rates.For example, the rates in...

2009-01-28 20:00:00

Lenetix Announces Successful Study of Improved Non-invasive Test Procedure MINEOLA, N.Y., Jan. 28 /PRNewswire/ -- Lenetix, Inc. today announced a significant step in the development of an improved first and second trimester non-invasive fetal chromosomal screening test to detect Down syndrome and other genetic fetal conditions. Lenetix presented preliminary study results at the 29th annual Society for Maternal-Fetal Medicine Conference in San Diego that indicate a potential breakthrough in...

2006-08-31 00:59:26

LOS ANGELES (Reuters) - The risk of miscarriage after undergoing chorionic villus sampling, or CVS, to detect birth defects is lower than previously thought and essentially carries the same risk than the more commonly used amniocentesis, according to new research. The findings, although based on a fairly small sample of cases, are important because most women prefer prenatal screening as early as possible in pregnancy, and CVS is performed about six weeks earlier than amniocentesis....

2006-07-12 16:40:05

NEW YORK (Reuters Health) - Hemolytic disease of the fetus can be detected accurately by using Doppler ultrasound to measure velocity of blood flow in the middle cerebral artery, the main artery supplying blood to the brain, doctors have found. Because ultrasound is noninvasive and safe, investigators believe this test can replace amniocentesis. Hemolytic disease of the fetus occurs when the mother carries antibodies that attack a protein called rhesus (Rh) D that may be found on...